Sort
51,593 grants matching “hepatitis”
The CNS Receptor For Asprosin
$570,005Atul Chopra · Case Western Reserve University · R01 · FY2022 · DK
Self-Assembly and Packaging of RNA and DNA in Viruses and Virus-like Particles
$570,000William M Gelbart · University Of California-Los Angeles · · FY2011 · MPS
Multidisciplinary Studies of Hematopoietic Malignancies
$569,965Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
Bio-digital Rapid Alert to Identify Neuromorbidity
$569,740Robert S. Clark · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · NS
Identifying, Characterizing and Inducing Effective Anti-HIV T Cell Responses
$569,726Helen Horton · Seattle Biomedical Research Institute · R01 · FY2012 · AI
Functional Role of BYDV 3' RNA Translational Enhancer Element
$569,715Dixie J Goss · Cuny Hunter College · · FY2015 · BIO
Chronic Hepatitis Intervention Project for Drug Users
$569,705Research Triangle Institute · R01 · FY2002 · DA
Novel HCV vaccine antigens and nanoparticles
$569,704Jiang Zhu · Scripps Research Institute, The · P01 · FY2023 · AI
Safety and Effectiveness of Medications for Alcohol Use Disorder among HIV+/-
$569,604E. Jennifer Edelman · Yale University · P01 · FY2025 · AA
Sulfur Amino Acid Metabolism in NAFLD
$569,509Satish C Kalhan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2009 · DK
Reducing HCV/HIV risks comparing two interventions
$569,491University Of Colorado Denver · R01 · FY2005 · DA
Insulin Stimulation of Hepatic Fatty Acid Synthesis via SREBP-1 c
$569,461Michael S Brown · Ut Southwestern Medical Center · P01 · FY2015 · HL
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy
$569,357Kim L Brouwer · Univ Of North Carolina Chapel Hill · R35 · FY2018 · GM
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy
$569,357Kim L Brouwer · Univ Of North Carolina Chapel Hill · R35 · FY2020 · GM
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy
$569,357Kim L Brouwer · Univ Of North Carolina Chapel Hill · R35 · FY2019 · GM
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy
$569,357Kim L Brouwer · Univ Of North Carolina Chapel Hill · R35 · FY2021 · GM
Preclinical studies of a heroin/morphine vaccine for opiate addiction
$569,342Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2014 · DA
ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESIS
$569,324Nicholas Davidson · Washington University · R01 · FY2010 · HL
Molecular & cellular mechanisms of hepatocellular polarity and biliary secretion
$569,280Irwin Arias · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
$569,273Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Epigenetic regulation of development and liver regeneration by UHRF1
$569,250Kirsten C Sadler Edepli · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · DK
Novel IP6K1 inhibitors for treatment of NAFLD/NASH
$569,142Xiaodong Wang · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DK
Impact of GLP-1 on Hepatic Fat and Energy Utilization in Obese Girls with Polycystic Ovarian Syndrome
$569,139Melanie G Cree · University Of Colorado Denver · R01 · FY2020 · DK
Epidemiology of Oncogenic Viruses
$569,110Thomas R O'Brien · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Studies of HCV Infection, Vaccine Development and HCV-Host interactions
$569,085T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK